San Diego, CA, United States of America

Dobrin Draganov

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dobrin Draganov

Introduction

Dobrin Draganov is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, Draganov is recognized for his work in enhancing therapeutic methods.

Latest Patents

Draganov's latest patents include "Enhanced systems for cell-mediated oncolytic viral therapy." This patent provides enhanced systems for potentiating cell-mediated oncolytic viral therapy, along with modified viruses for such systems and methods of treating cancers by administering these systems. His second patent, "Cell-based vehicles for potentiation of viral therapy," details carrier cells and virus combinations, methods for cancer treatment, and modified carrier cells tailored for such treatments.

Career Highlights

Draganov is currently associated with Calidi Biotherapeutics, Inc., where he continues to develop innovative solutions in the biotherapeutics sector. His work focuses on advancing cancer therapies that utilize viral mechanisms to target and destroy cancer cells effectively.

Collaborations

Throughout his career, Draganov has collaborated with esteemed colleagues, including Aladar A Szalay and Antonio Fernandez Santidrian. These collaborations have further enriched his research and development efforts in the field of biotherapeutics.

Conclusion

Dobrin Draganov's contributions to cancer treatment through his innovative patents highlight his commitment to advancing medical science. His work at Calidi Biotherapeutics, Inc. continues to pave the way for new therapeutic approaches in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…